| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,300 | 3,460 | 25.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN
|
Leser | Medien | ||
|---|---|---|---|---|---|
| NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
| 03.08. | NANOVIRICIDES, INC. - 8-K, Current Report | 14 | SEC Filings | ||
| 21.07. | NanoViricides, Inc.: NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020 | 1.002 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / July 21, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen |
|
| 13.07. | NANOVIRICIDES, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 13.07. | NanoViricides, Inc.: NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock | 1.194 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / July 13, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen |
|
| 09.07. | NanoViricides prices stock offering at $7.30 | 4 | Seeking Alpha | ||
| 09.07. | NanoViricides, Inc.: NanoViricides Prices $10.0 Million Underwritten Public Offering of Common Stock | 1.216 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / July 9, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen |
|
| 09.07. | Nanoviricides commences public offering of common stock | 9 | Seeking Alpha | ||
| 08.07. | Why NanoViricides Stock Is Trading Higher Today | 7 | Benzinga.com | ||
| 08.07. | NanoViricides leads consumer gainers; CTI BioPharma and Evolus among losers | 17 | Seeking Alpha | ||
| 08.07. | Pre-market Movers In Healthcare Sector: NNVC, BCRX, XENT, VVUS… | 31 | RTTNews | ||
| 08.07. | Stock Alert: NanoViricides Stock Up 50% In Early Trade | 5 | RTTNews | ||
| 08.07. | Nanoviricides +54% on advancement of SARS-CoV-2 therapeutics program | 9 | Seeking Alpha | ||
| 08.07. | NanoViricides, Inc.: Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides' SARS-CoV-2 Therapeutics Program | 638 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / July 8, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen |
|
| 30.06. | NanoViricides added to Russell Microcap index | 3 | Seeking Alpha | ||
| 30.06. | NanoViricides, Inc.: NanoViricides Announces Addition to Russell Microcap(R) Index | 1.185 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / June 30, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen |
|
| 23.06. | NanoViricides provides business update | 12 | Seeking Alpha | ||
| 23.06. | NanoViricides reports Q3 results | 8 | Seeking Alpha | ||
| 23.06. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2020 - Has Sufficient Cash, Progress on New Coronavirus Drug Program and the Lead HerpeCide Drug Candidate IND Application | 1.053 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / June 23, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen |
|
| 22.06. | NANOVIRICIDES, INC. - 10-Q, Quaterly Report | 4 | SEC Filings | ||
| 09.06. | Stock Alert: NanoViricides Signs MoU For Human Coronavirus Drug Development License; Stock Up 10% | 14 | RTTNews |
Seite:
1 2 3 4 Weiter >>
80 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NANOGATE | 1,150 | -0,86 % | Sanierung in Eigenverantwortung angestrebt: Nanogate startet Schutzschirmverfahren | Das Management von Nanogate wird jetzt gemeinsam mit dem Sanierungsexperten Matthias Bayer und Rechtsanwalt Franz Abel (beide Kanzlei Abel und Kollegen) die Restrukturierungsmaßnahmen erarbeiten. Beide... ► Artikel lesen |
|
| MAGFORCE | 2,880 | -1,71 % | DGAP-News: MagForce AG gibt positive Ergebnisse der Hauptversammlung 2020 bekannt (deutsch) | MagForce AG gibt positive Ergebnisse der Hauptversammlung 2020 bekannt DGAP-News: MagForce AG / Schlagwort(e): Hauptversammlung MagForce AG gibt positive Ergebnisse der Hauptversammlung 2020 bekannt... ► Artikel lesen |
|
| NOVAVAX | 96,23 | -4,89 % | Impfstoff-Hoffnungsträger Astrazeneca, Novavax und Co: Politik sorgt für Unruhe | Gesundheitsexperten und führende Demokraten haben US-Präsident Donald Trump dafür kritisiert, die für die Zulassung eines Corona-Impfstoffs zuständige Behörde unter Druck zu setzen. Die Aktien der Impfstoff-Hersteller... ► Artikel lesen |
|
| FORMYCON | 24,100 | +0,42 % | DGAP-News: Formycon AG: Formycon und Bioeq schließen ersten Patienten in Phase-III-Studie mit Aflibercept-Biosimilar (FYB203) ein | DGAP-News: Formycon AG
/ Schlagwort(e): Studie/Sonstiges
Formycon und Bioeq schließen ersten Patienten in Phase-III-Studie mit Aflibercept-Biosimilar (FYB203) ein
24.08.2020 / 07:00... ► Artikel lesen |
|
| STARPHARMA | 0,778 | +21,09 % | Starpharma share price bolts 14% on COVID-19 nasal spray | ||
| KOPIN | 1,190 | +2,59 % | EARNINGS SUMMARY: Details of Kopin Corp Q2 Earnings Report | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Kopin Corp (KOPN):-Earnings: -$1.12 million in Q2 vs. -$4.26 million in the same period last year.
-EPS: -$0.01 in Q2 vs. -$0.05... ► Artikel lesen |
|
| NANOFORM FINLAND | 4,478 | +0,54 % | Nanoform convenes EGM to elect Cynthia Schwalm as board member | HELSINKI, Finland, Aug. 6, 2020 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, will convene an extraordinary general meeting (EGM)... ► Artikel lesen |
|
| SIXTH WAVE INNOVATIONS | 0,193 | +2,12 % | Sixth Wave Innovations Inc: Sixth Wave arranges $3-million private placement | ||
| OBDUCAT | 0,150 | +650,00 % | OBDUCAT AB: Obducat receives order for an EITRE 3 NIL-system from University of Cambridge | ||
| ADVANCE NANOTEK | 2,180 | +4,31 % | XFRA BBJ: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT... ► Artikel lesen |
|
| ITN NANOVATION | 0,170 | +18,06 % | PTA-AFR: ItN Nanovation AG: Korrektur zur Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | Vorabbekanntmachung Finanzberichte gemäß §§ 114-117 WpHG Saarbrücken (pta024/29.07.2020/16:00) - ItN Nanovation AG gibt hiermit bekannt, dass folgende Finanzberichte veröffentlicht werden: Bericht:... ► Artikel lesen |
|
| VEECO INSTRUMENTS | 10,450 | +0,48 % | Veeco Instruments Inc. Up 80%, More to Come on Game-Changing Strategy | Veeco Instruments Inc. Could Surge in Restructuring Efforts
The majority of small-cap technology growth stocks have surged from their March lows. That's certainly the case with semiconductor company... ► Artikel lesen |
|
| ONTO INNOVATION | 27,400 | -0,72 % | Onto Innovation (ONTO) Q2 Earnings & Revenues Beat Estimates | ||
| ACACIA RESEARCH | 3,240 | -0,61 % | Acacia Research Corporation (ACTG) CEO Clifford Press on Q2 2020 Results - Earnings Call Transcript | ||
| NVE | 44,800 | +0,45 % | NVE Corporation's Current Bet |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
